VR Logo

bluebird bio Inc. (BLUE) download report


Healthcare | Biotechnology & Pharma Research

bluebird bio Inc. (BLUE) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases.

IPO Date: 19-Jun-2013

Pres, CEO & Director: Mr. Andrew Obenshain

Treasurer, Principal Accounting Officer & Financial Officer and Chief Strategy & Financial Officer: Mr. Jason F. Cole Esq.

Listing: NASDAQ: BLUE

Country: United States

Headquarters: Cambridge, MA

Website: https://www.bluebirdbio.com

Key Facts

Market cap: $327.26 Mln

Revenue (TTM): $-7.19 Mln

Earnings (TTM): $-735.72 Mln

Cash: $211.59 Mln

Total Debt: $110.34 Mln

Insider's Holding: 1.16%

Liquidity: Low

52 Week range: $2.87 - 21.16

Shares outstanding: 71,453,696

10 Years Aggregate:

  • CFO: $-2,689.72 Mln
  • EBITDA: $-3,501.31 Mln
  • Net Profit: $-3,646.94 Mln

Stock Performance

Time Period bluebird bio (BLUE) S&P BSE Sensex* S&P Small-Cap 600*
YTD-58.56-9.18-19.53
1 month26.22-4.78-9.69
3 months-20.38-9.66-16.90
1 Year-78.740.81-17.67
3 Years-63.0910.335.77
5 Years-43.2111.345.69
10 Years--11.749.74
As on 30-Jun-2022 *As on 01-Jul-2022
Year bluebird bio (BLUE) S&P Small-Cap 600 S&P BSE Sensex
2021-64.3425.2721.99
2020-50.699.5715.75
2019-11.5420.8614.38
2018-44.12-9.705.87
2017188.6511.7327.91
2016-3.9224.741.95
2015-29.98-3.36-5.03